ArticleCardiovascular research2026
Cardiomyocyte derived extracellular mitochondria in activation of macrophages during oxidative stress.
Article in Cardiovascular research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
aimsMitochondria serve as central hubs for aerobic metabolism and regulators of cell fate. Damage to mitochondria induced by oxidative stress contributes to cardiac injury. We investigate whether oxidative stress causes the release of mitochondria into the extracellular space and whether these extracellular mitochondria (EM) mediate the detrimental effect of oxidative stress. METHODS AND
resultsAC16 cardiomyocytes were exposed to sublethal doses of H2O2 to collect mitochondria released into the conditioned culture medium. These EM were compared with intracellular mitochondria (IM) for morphology, size, membrane potential, and metabolic profile using liquid chromatography-tandem mass spectrometry-based metabolomics. Cellular ceramide content was measured by lipidomics to determine the role of ceramide synthesis in mitochondrial release. EM were tested for the ability to activate THP-1 macrophages. Oxidants caused an increase in EM. While EM from stressed cells did not show a significant difference from those of non-stressed cells in overall morphology, size, or surface charge, EM exhibited disrupted cristae structure, smaller size, reduced membrane potential, and decreased levels of nicotinamide adenine dinucleotide, adenosine triphosphate, adenosine diphosphate, and adenosine monophosphate compared to IM. H2O2 treatment upregulated several ceramide species in AC16 cells and the inhibition of ceramide synthesis markedly reduced EM release under oxidative stress. Functionally, EM activated M1 and M2 like macrophages, as indicated by increased expression of the cytokine markers tumour necrosis factor α and CD163.
conclusionOxidative stress enhanced the release of mitochondria from cardiomyocytes into the extracellular space. These EM differ from IM in their smaller sizes, reduced membrane potential, and depressed metabolic state. At high abundance, EM act as mediators that promote macrophage activation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.